You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Succinylcholine versus rocuronium for rapid sequence intubation in intensive care: a prospective, randomized controlled trial
|
|---|---|
| Published in |
Critical Care, August 2011
|
| DOI | 10.1186/cc10367 |
| Pubmed ID | |
| Authors |
Stephan C Marsch, Luzius Steiner, Evelyne Bucher, Hans Pargger, Martin Schumann, Timothy Aebi, Patrick R Hunziker, Martin Siegemund |
| Abstract |
Succinylcholine and rocuronium are widely used to facilitate rapid sequence induction (RSI) intubation in intensive care. Concerns relate to the side effects of succinylcholine and to slower onset and inferior intubation conditions associated with rocuronium. So far, succinylcholine and rocuronium have not been compared in an adequately powered randomized trial in intensive care. Accordingly, the aim of the present study was to compare the incidence of hypoxemia after rocuronium or succinylcholine in critically ill patients requiring an emergent RSI. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 25% |
| Spain | 1 | 25% |
| Mexico | 1 | 25% |
| Unknown | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 145 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Colombia | 2 | 1% |
| France | 1 | <1% |
| Italy | 1 | <1% |
| South Africa | 1 | <1% |
| Canada | 1 | <1% |
| Belgium | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 137 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 21 | 14% |
| Researcher | 20 | 14% |
| Student > Master | 18 | 12% |
| Professor | 14 | 10% |
| Student > Bachelor | 13 | 9% |
| Other | 36 | 25% |
| Unknown | 23 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 92 | 63% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 3% |
| Agricultural and Biological Sciences | 4 | 3% |
| Nursing and Health Professions | 4 | 3% |
| Biochemistry, Genetics and Molecular Biology | 2 | 1% |
| Other | 9 | 6% |
| Unknown | 29 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 April 2020.
All research outputs
#3,193,513
of 25,368,786 outputs
Outputs from Critical Care
#2,607
of 6,554 outputs
Outputs of similar age
#14,850
of 121,683 outputs
Outputs of similar age from Critical Care
#7
of 57 outputs
Altmetric has tracked 25,368,786 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,554 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,683 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.